Driehaus Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22M | Sell |
606,407
-246,250
| -29% | -$8.95M | 0.18% | 167 |
|
|
2025
Q1 | $30.9M | Buy |
852,657
+23,192
| +3% | +$840K | 0.3% | 108 |
|
|
2024
Q4 | $34.9M | Buy |
829,465
+45,521
| +6% | +$1.92M | 0.29% | 113 |
|
|
2024
Q3 | $43.5M | Buy |
783,944
+255,764
| +48% | +$14.2M | 0.37% | 91 |
|
|
2024
Q2 | $21.7M | Buy |
528,180
+138,889
| +36% | +$5.71M | 0.21% | 141 |
|
|
2024
Q1 | $18.2M | Buy |
389,291
+30,125
| +8% | +$1.41M | 0.18% | 167 |
|
|
2023
Q4 | $17.2M | Buy |
359,166
+137,920
| +62% | +$6.6M | 0.21% | 157 |
|
|
2023
Q3 | $7.89M | Sell |
221,246
-108,422
| -33% | -$3.87M | 0.1% | 238 |
|
|
2023
Q2 | $15.2M | Buy |
+329,668
| New | +$15.2M | 0.19% | 167 |
|
|
2014
Q4 | – | Sell |
-61,146
| Closed | -$3.46M | – | 563 |
|
|
2014
Q3 | $3.46M | Sell |
61,146
-30,729
| -33% | -$1.74M | 0.13% | 208 |
|
|
2014
Q2 | $4.12M | Buy |
91,875
+29,921
| +48% | +$1.34M | 0.13% | 211 |
|
|
2014
Q1 | $3.03M | Buy |
+61,954
| New | +$3.03M | 0.1% | 257 |
|